PTCT
PTC Therapeutics Inc
Price:  
31.54 
USD
Volume:  
642,815.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PTCT WACC - Weighted Average Cost of Capital

The WACC of PTC Therapeutics Inc (PTCT) is 7.4%.

The Cost of Equity of PTC Therapeutics Inc (PTCT) is 9.10%.
The Cost of Debt of PTC Therapeutics Inc (PTCT) is 5.50%.

Range Selected
Cost of equity 6.60% - 11.60% 9.10%
Tax rate 4.90% - 6.40% 5.65%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.4% - 9.4% 7.4%
WACC

PTCT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.59 1.2
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.60% 11.60%
Tax rate 4.90% 6.40%
Debt/Equity ratio 0.78 0.78
Cost of debt 4.00% 7.00%
After-tax WACC 5.4% 9.4%
Selected WACC 7.4%